Cancer progression gene expression profiling identifies the urokinase plasminogen activator receptor as a biomarker of metastasis in cutaneous squamous cell carcinoma E Minaei, SA Mueller, B Ashford, AS Thind, J Mitchell, JR Perry, ... Frontiers in oncology 12, 835929, 2022 | 12 | 2022 |
A tEMTing target? Clinical and experimental evidence for epithelial-mesenchymal transition in the progression of cutaneous squamous cell carcinoma (a scoping systematic review) B Genenger, JR Perry, B Ashford, M Ranson Discover Oncology 13 (1), 42, 2022 | 7 | 2022 |
Sex as a Predictor of Response to Immunotherapy in Advanced Cutaneous Squamous Cell Carcinoma N Yeo, B Genenger, M Aghmesheh, A Thind, S Napaki, J Perry, B Ashford, ... Cancers 15 (20), 5026, 2023 | 1 | 2023 |
PIK Your Poison: The Effects of Combining PI3K and CDK Inhibitors against Metastatic Cutaneous Squamous Cell Carcinoma In Vitro JR Perry, B Genenger, AS Thind, B Ashford, M Ranson Cancers 16 (2), 370, 2024 | | 2024 |
Protocol for the generation and automated confocal imaging of whole multi-cellular tumor spheroids B Genenger, L McAlary, JR Perry, B Ashford, M Ranson STAR protocols 4 (2), 102331, 2023 | | 2023 |
Targeting the PI3K/AKT/mTOR pathway in cutaneous squamous cell carcinoma JR Perry, AS Thind, E Minaei, E Ryan, B Genenger, G Iyer, C Martin, ... ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 17, 43-43, 2021 | | 2021 |
Inhibition of focal adhesion kinase in cutaneous squamous cell carcinoma B Genenger, J Perry, L McAllary, A Thind, B Ashford, M Ranson ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 17, 44-44, 2021 | | 2021 |